نتائج البحث - "Lactate dehydrogenase"

1

Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal Cancer

المؤلفون: Masaichi Ohira, Hisashi Nagahara, Tatsunari Fukuoka, Kosei Hirakawa, Kiyoshi Maeda, Yuki Okazaki, Masatsune Shibutani, En Wang, Shinichiro Kashiwagi, Yasuhito Iseki

المصدر: Anticancer research. 41(7)

مصطلحات موضوعية: Oncology, Adult, Male, Vascular Endothelial Growth Factor A, Cancer Research, medicine.medical_specialty, Bevacizumab, Adolescent, Colorectal cancer, Angiogenesis, medicine.medical_treatment, Angiogenesis Inhibitors, Disease-Free Survival, chemistry.chemical_compound, Young Adult, Lactate dehydrogenase, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Medicine, Humans, Aged, Aged, 80 and over, Chemotherapy, biology, L-Lactate Dehydrogenase, Neovascularization, Pathologic, business.industry, Growth factor, General Medicine, Hypoxia (medical), Middle Aged, medicine.disease, chemistry, biology.protein, Female, medicine.symptom, Antibody, business, Colorectal Neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45ed41c97171a50fcf10fe8af142b8aTest
https://pubmed.ncbi.nlm.nih.gov/34230149Test

2

Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma

المؤلفون: Toru Nakanishi, Kenichi Harano, Nobuyuki Susumu, Reiko Watanabe, Hitoshi Tsuda, Yutaka Ueda, Norihiro Teramoto, Hideki Tokunaga, Toshiaki Saito, Yoshihito Yokoyama, Natsumi Yamashita, Kazuhiro Takehara, Takashi Motohashi

المصدر: Gynecologic Oncology. 157:115-120

مصطلحات موضوعية: Adult, Leiomyosarcoma, 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, education, Docetaxel, Deoxycytidine, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Japan, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Adjuvant therapy, Humans, Stage (cooking), Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Clinical Trials as Topic, Chemotherapy, L-Lactate Dehydrogenase, business.industry, Obstetrics and Gynecology, Middle Aged, Prognosis, medicine.disease, Gemcitabine, Progression-Free Survival, Clinical trial, Regimen, 030104 developmental biology, 030220 oncology & carcinogenesis, Uterine Neoplasms, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46c8c8af71539c02baf138b5e5b0d451Test
https://doi.org/10.1016/j.ygyno.2020.01.022Test

3

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

المؤلفون: Eric Winquist, Darren R. Feldman, Ignacio Duran, Andrea Necchi, Silke Gillessen, Alexey Tryakin, David J. Vaughn, Angelika Terbuch, Axel Heidenreich, Christopher Sweeney, Enrique Gonzalez-Billalabeitia, Anna Patrikidou, Aaron R. Hansen, Daniel Y.C. Heng, Jonathan Shamash, Costantine Albany, Peter Grimison, Robert Huddart, Anja Lorch, Carsten Bokemeyer, Torgrim Tandstad, Cora N. Sternberg, Ugo De Giorgi, Marko Bebek, Jörg Beyer, Gedske Daugaard, Nicolas Sauvé, Richard Cathomas, Ronald de Wit, Laurence Collette, Christian D. Fankhauser, Helene F. S. Negaard, Olof Ståhl, Stéphane Culine, Ben Tran, Michal Chovanec, Samson Assele, Marcus Hentrich, Fay H. Cafferty, Dan Stark, Jourik A. Gietema

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Beyer, J., Collette, L., Sauve, N., Daugaard, G., Feldman, D. R., Tandstad, T., Tryakin, A., Stahl, O., Gonzalez-Billalabeitia, E., de Giorgi, U., Culine, S., de Wit, R., Hansen, A. R., Bebek, M., Terbuch, A., Albany, C., Hentrich, M., Gietema, J. A., Negaard, H., Huddart, R. A., Lorch, A., Cafferty, F. H., Heng, D. Y. C., Sweeney, C. J., Winquist, E., Chovanec, M., Fankhauser, C., Stark, D., Grimison, P., Necchi, A., Tran, B., Heidenreich, A., Shamash, J., Sternberg, C. N., Vaughn, D. J., Duran, I., Bokemeyer, C., Patrikidou, A., Cathomas, R., Assele, S., Gillessen, S.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(14), 1553-1562. AMER SOC CLINICAL ONCOLOGY

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d90b125dd0e7e4cb884df8b95a5af6cfTest

4

The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis

المؤلفون: Takahiro Kogawa, Ako Hosono, Kenichi Harano, Ayumi Komuro, Yoichi Naito, Chihiro Kondoh, Kanako Mamishin, Shota Kusuhara, Chikako Funasaka, Toru Mukohara, Takehiro Nakao, Mashiro Okunaka, Toshikatsu Kawasaki, Yoko Fukasawa, Nobuaki Matsubara

المصدر: The Breast : Official Journal of the European Society of Mastology
Breast, Vol 58, Iss, Pp 50-56 (2021)

مصطلحات موضوعية: MBC, metastatic breast cancer, Receptor, ErbB-2, medicine.medical_treatment, AST, aspartate aminotransferase, Gastroenterology, TTF, time to treatment failure, ORR, objective response rate, chemistry.chemical_compound, Paclitaxel plus bevacizumab, 0302 clinical medicine, Breast cancer, Antineoplastic Combined Chemotherapy Protocols, HER2, human epidermal growth factor receptor 2, 030212 general & internal medicine, wPTX, weekly paclitaxel, Lymphangiomatosis, RC254-282, LDH, lactate dehydrogenase, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Metastatic breast cancer, PS, performance status, Bevacizumab, Treatment Outcome, Paclitaxel, 030220 oncology & carcinogenesis, Female, Original Article, medicine.symptom, AE, adverse event, medicine.drug, DCR, disease control rate, medicine.medical_specialty, Vena Cava, Superior, Breast Neoplasms, SVC, superior vena cava, OS, overall survival, 03 medical and health sciences, Internal medicine, ALT, alanine aminotransferase, medicine, Humans, Chemotherapy, Adverse effect, Retrospective Studies, business.industry, Organ dysfunction, Visceral crisis, BV, bevacizumab, medicine.disease, chemistry, Surgery, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceeb2f8c28b19a71d25194b192d9cf8fTest
https://pubmed.ncbi.nlm.nih.gov/33901922Test

5

Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence

المؤلفون: Rafał Suwiński, Anna Dawidowska, Bożena Cybulska-Stopa, Paweł Teterycz, Marcin Rajczykowski, Iwona Ługowska, Piotr Rutkowski, Karolina Piejko, Anna M. Czarnecka, Paweł Rogala, Jacek Mackiewicz, Łukasz Galus

المصدر: Advances in medical sciences. 65(2)

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Lactate dehydrogenase, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Brain Neoplasms, Standard treatment, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Prognosis, Survival Rate, Nivolumab, chemistry, 030220 oncology & carcinogenesis, Toxicity, Female, business, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cffa4b60f90fea43f51452e88933159Test
https://pubmed.ncbi.nlm.nih.gov/32554313Test

6

Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)

المؤلفون: Sergio Vázquez, Jose Miguel Cuevas Sanz, A. González-del-Alba, Alvaro Pinto, Jacobo Muñoz del Toro, Ángela García García-Porrero, Ángel Francisco Zazo Rodríguez, Javier Puente, Eduardo Useros Rodríguez, Núria Sala-González, María José Méndez-Vidal

المساهمون: [Puente,J] Medical Oncology, Hospital Clínico San Carlos. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC. Madrid, Spain. [González-del-Alba,A] Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. [Sala-Gonzalez,N] Medical Oncology, ICO Girona, Hospital Josep Trueta, Girona, Spain. [Méndez-Vidal,MJ] Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC). Reina Sofía Hospital. University of Córdoba, Cordoba, Spain. [Pinto,A] Medical Oncology, University Hospital La Paz - IdiPAZ, Madrid, Spain. [Rodríguez,A] Medical Oncology, Hospital Universitario de León, León, Spain. [Cuevas Sanz,JM] Medical Oncology, Hospital Universitario de la Ribera, Alcira, Spain. [Muñoz del Toro,JR, Useros Rodríguez,E, García García-Porrero,A] Medical Department, Janssen-Cilag S.A., Madrid, Spain. [Vázquez,S] Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., This study was funded by Janssen Cilag S.A.

المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)